The Discounted Cash Flow (DCF) valuation of BCAL Diagnostics Ltd (BDX.AX) is (3.49) AUD. With the latest stock price at 0.06 AUD, the upside of BCAL Diagnostics Ltd based on DCF is -6335.8%.
Based on the latest price of 0.06 AUD and our DCF valuation, BCAL Diagnostics Ltd (BDX.AX) is a sell. selling BDX.AX stocks now will result in a potential gain of 6335.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 8.9% - 13.0% | 10.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (6.22) - (2.42) | (3.49) |
| Upside | -11198.5% - -4428.3% | -6335.8% |